AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

MammoMark available for breast biopsy site identification.(Brief Article)

Women's Health Weekly

| April 04, 2002 | COPYRIGHT 2002 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2002 APR 4 - (NewsRx.com & NewsRx.net) -- Artemis Medical, Inc., announced the commercial release of the MammoMark Biopsy Site Identifier for breast biopsy site identification. The MammoMark is specifically designed to facilitate more accurate and precise postprocedure identification of the biopsy site.

The MammoMark is the first breast biopsy site identifier to incorporate self-expanding collagen with a centrally located titanium clip. When placed in the biopsy site, the MammoMark rapidly hydrates and conforms to the size and shape of the biopsy cavity. The MammoMark is echogenic and radiopaque providing physicians the advantage of precise identification of the biopsy site using ultrasound or mammography. Within a matter of weeks, the MammoMark resorbs, leaving the centrally placed titanium clip for long-term follow-up.

"The Artemis MammoMark offers several advantages over current marking devices," stated Laurie Fajardo, Chief of Breast Imaging and Intervention in the Russell Morgan Department of Radiology ...

Related articles from newspapers, magazines, journals, and more
Artemis Medical(R) Releases New Products for More Accurate Diagnosis And...
Press release article from: PR Newswire October 28, 2003 700+ words
...28 /PRNewswire/ -- Artemis Medical, a privately held company...product being released by Artemis Medical is the SkiPOLE Breast...of the CorMARK Breast Biopsy Site Identifier strengthens Artemis Medical's market leadership...
Artemis Medical Issued Additional Patents for Its Breast Marking Technology.
Press release article from: PR Newswire March 9, 2004 700+ words
...PRNewswire/ -- Artemis Medical, Inc. announced...significantly broaden Artemis Medical's proprietary...for marking a biopsy site using a swellable...location of the biopsy site," said Judith...invasively. Artemis Medical manufactures...
Artemis Medical(R), Inc. Announces Participation in the MedTech Insight...
Press release article from: PR Newswire February 22, 2002 700+ words
HAYWARD, Calif. -- Artemis Medical Inc. announces participation...California February 21st and 22nd. Artemis Medical Inc., based in Hayward, California...Stant, President and CEO of Artemis Medical. "We have recently introduced...
Artemis Medical(R) Receives 510K Clearance on New Image Guided Biopsy Device.
Press release article from: PR Newswire April 23, 2002 700+ words
HAYWARD, Calif. -- Artemis Medical, Inc., a privately held company...represents an important milestone for Artemis Medical," stated Judith Stant, President and Chief Executive Officer of Artemis Medical, Inc. "Radiologists and surgeons...
Artemis Medical receives 510K clearance on new image-guided biopsy device.
Newspaper article from: Cancer Weekly May 28, 2002 700+ words
...com & NewsRx.net) -- Artemis Medical, Inc., a privately held company...represents an important milestone for Artemis Medical," stated Judith Stant, president and CEO of Artemis Medical, Inc. "Radiologists and surgeons...
Artemis Medical receives 510K clearance on new image-guided biopsy...
Newspaper article from: Medical Devices & Surgical Technology Week June 2, 2002 700+ words
...com & NewsRx.net) -- Artemis Medical, Inc., a privately held company...represents an important milestone for Artemis Medical," stated Judith Stant, president and CEO of Artemis Medical, Inc. "Radiologists and surgeons...
Best biopsy site for drug-induced, non-alcoholic steatohepatitis decided.
Newspaper article from: Hepatitis Weekly February 10, 2003 700+ words
...infiltration in the liver for determination of a suitable biopsy site for diagnosis of tamoxifen-induced non-alcoholic steatohepatitis...patients with breast cancer: Determination of a suitable biopsy site for diagnosis. Oncol Rep, 2003;10(1):97-100...
Publication No. EP2092893 Published on Aug. 26, Assigned to Ethicon...
News wire article from: US Fed News Service, Including US State News September 1, 2009 700+ words
...Sep. 1 -- Shailendra K. Parihar, Michael R. Ludzack and Wells D. Haberstitch, all from the U.S., have developed a biopsy site marker applier. The patent has been assigned to Ethicon Endo-Surgery Inc., Cincinnati. According to an abstract posted...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA